Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | ACE-232 |
Synonyms | |
Therapy Description |
Limited information is currently available on ACE-232, a putative CYP11A1 inhibitor (Feb 2025). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
ACE-232 | ACE 232|ACE232 | Limited information is currently available on ACE-232, a putative CYP11A1 inhibitor (Feb 2025). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06801236 | Phase I | ACE-232 | Phase 1 Study of ACE-232 to Treat Patients with Metastatic Castration-Resistant Prostate Cancer | Not yet recruiting | USA | 0 |